Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review.

ABSTRACT: Introduction: In the last few decades, there has been a rapid development in cancer therapies and improved detection strategies, hence the death rates caused by cancer have decreased. However, it has been reported that cardiovascular disease has become the second leading cause of long-term morbidity and fatality among cancer survivors. Cardiotoxicity from anticancer drugs affects the heart's function and structure and can occur during any stage of the cancer treatments, which leads to the development of cardiovascular disease. Objectives: To investigate the association between anticancer drugs for non-small cell lung cancer (NSCLC) and cardiotoxicity as to whether: different classes of anticancer drugs demonstrate different cardiotoxicity potentials; different dosages of the

SUBMITTER: Chan SHY 

PROVIDER: S-EPMC10294714 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature